Inspire Advisors, LLC Citius Pharmaceuticals, Inc. Transaction History

Inspire Advisors, LLC

$737 Million
Q3 2024

A detailed history of Inspire Advisors, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Inspire Advisors, LLC holds 157,938 shares of CTXR stock, worth $34,746. This represents 0.01% of its overall portfolio holdings.

Number of Shares

157,938

Previous 158,244 0.19%

Holding current value

$34,746

Previous $91,000 14.29%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$0.48 - $1.02 $146 - $312	-306 Reduced 0.19%	157,938 $78,000
Q2 2024 Aug 08, 2024	BUY	$0.58 - $1.03 $474 - $842	818 Added 0.52%	158,244 $91,000
Q1 2024 May 07, 2024	SELL	$0.6 - $0.9 $15,187 - $22,781	-25,313 Reduced 13.85%	157,426 $141,000
Q4 2023 Feb 12, 2024	SELL	$0.65 - $0.86 $2,386 - $3,157	-3,671 Reduced 1.97%	182,739 $138,000
Q3 2023 Oct 26, 2023	SELL	$0.65 - $1.25 $7,840 - $15,077	-12,062 Reduced 6.08%	186,410 $126,000
Q2 2023 Jul 31, 2023	SELL	$1.08 - $1.65 $172 - $264	-160 Reduced 0.08%	198,472 $238,000
Q1 2023 Apr 24, 2023	BUY	$0.78 - $1.42 $2,095 - $3,814	2,686 Added 1.37%	198,632 $232,000
Q4 2022 Jan 26, 2023	SELL	$0.79 - $1.28 $1,942 - $3,147	-2,459 Reduced 1.24%	195,946 $0
Q3 2022 Nov 07, 2022	BUY	$0.14 - $1.33 $215 - $2,045	1,538 Added 0.78%	198,405 $240,000
Q2 2022 Aug 10, 2022	BUY	$0.88 - $1.87 $2,773 - $5,894	3,152 Added 1.63%	196,867 $181,000
Q1 2022 Apr 21, 2022	BUY	$1.38 - $1.89 $6,788 - $9,296	4,919 Added 2.61%	193,715 $347,000
Q4 2021 Feb 03, 2022	BUY	$1.51 - $2.2 $76,380 - $111,282	50,583 Added 36.6%	188,796 $291,000
Q3 2021 Nov 09, 2021	BUY	$1.74 - $2.6 $4,706 - $7,033	2,705 Added 2.0%	138,213 $281,000
Q2 2021 Aug 10, 2021	BUY	$1.51 - $4.23 $37,328 - $104,569	24,721 Added 22.31%	135,508 $472,000
Q1 2021 Apr 30, 2021	BUY	$1.04 - $2.34 $115,218 - $259,241	110,787 New	110,787 $197,000

Others Institutions Holding CTXR

# of Institutions

Shares Held

23.4M

Call Options Held

83.1K

Put Options Held

32.1K

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $32.1M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Advisors, LLC with notifications on news.

Account

Inspire Advisors, LLC Citius Pharmaceuticals, Inc. Transaction History